Decision making in Parkinson's disease: Analysis of behavioral and physiological patterns in the Iowa Gambling task

Movement Disorders

Volumn 23, Issue 4, 2008, Pages 547-552

  Kobayakawa, Mutsutaka ^a   Koyama, Shinichi ^a,b   Mimura, Masaru ^a   Kawamura, Mitsuru ^a,c  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Decision making; Iowa gambling task; Parkinson's disease; Skin conductance response; Social cognition

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

AGE; AGED; AMYGDALOID NUCLEUS; ARTICLE; BEHAVIOR; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DECISION MAKING; DISEASE SEVERITY; EDUCATION; ELECTRODERMAL RESPONSE; EMOTION; FEMALE; HUMAN; MALE; MENTAL TASK; MINI MENTAL STATE EXAMINATION; MOTOR PERFORMANCE; PARKINSON DISEASE; PRIORITY JOURNAL; TASK PERFORMANCE; COGNITIVE DEFECT; HIGH RISK BEHAVIOR; HOSPITALIZATION; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; PATHOLOGICAL GAMBLING; PATHOPHYSIOLOGY; PERCEPTION; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR DISORDER; VISION;

AGED; AMYGDALA; COGNITION DISORDERS; DECISION MAKING; FEMALE; GALVANIC SKIN RESPONSE; GAMBLING; HUMANS; MALE; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PROSPECTIVE STUDIES; PSYCHOLOGICAL TESTS; PSYCHOMOTOR DISORDERS; RISK-TAKING; SEVERITY OF ILLNESS INDEX; SOCIAL PERCEPTION; VISUAL PERCEPTION;

EID: 47549086912     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21865     Document Type: Article

References (35)

1. Brown RG, Marsden CD. Cognitive function in Parkinson's disease: from description to theory. Trends Neurosci 1990;13:21-29.
2. Adler CH. Nonmotor complications in Parkinson's disease. Mov Disord 2005;20 (Suppi II):S23-S29.
3. Ramirez-Ruiz B, Junque C, Marti MJ, Valldeoriola. F, Tolosa E. Neuropsychological deficits in Parkinson's disease patients with visual hallucinations. Mov Disord 2006;21:1483-1487.
4. Kan Y, Kawamura M, Hasegawa Y, Mochizuki S, Nakamura K. Recognition of emotion from facial, prosodic and written verbal stimuli in Parkinson's disease. Cortex 2002;38:623-630.
5. Kan Y, Mimura M, Kamijima K, Kawamura M. Recognition of emotion from moving facial and prosodic stimuli in depressed patients. J Neurol Neurosurg Psychiatry 2004;75:1667-1671.
6. Suzuki A, Hoshino T, Shigemasu K, Kawamura M. Disgust-specific impairment of facial expression recognition in Parkinson's disease. Brain 2006;129:707-717.
7. Yoshimura N, Kawamura M, Masaoka Y, Homma I. The amygdala of patients with Parkinson's disease is silent in response to fearful facial expressions. Neuroscience 2005;131:523-534.
8. Kawamura M, Koyama S. Social cognitive impairment in Parkinson's Disease. J Neurol 2007; Suppl 4; IV49-IV53.
9. Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994;50:7-15.
10. Mimura M, Oeda R, Kawamura M. Impaired decision-making in Parkinson's disease. Parkinsonism Relat Disord 2006;12:169-175.
11. Czernecki V, Pillon B, Houeto JL, Pochon JB, Levy R, Dubois B. Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia 2002;40:2257-2267.
12. Thiel A, Hilker R, Kessler J, Habedank B, Herholz K, Heiss WD. Activation of basal ganglia loops in idiopathic Parkinson's disease: a PET study. J Neural Transm 2003; 110:1289-1301.
13. Perretta JG, Pari G, Beninger RJ. Effects of Parkinson disease on two putative nondeclarative learning tasks: probabilistic classification and gambling. Cogn Behav Neurol 2005;18:185-192.
14. Stout JC, Rodawalt WC, Siemers ER. Risky decision making in Huntington's disease. J Int Neuropsychol Soc 2001;7:92-101.
15. Pagonabarraga J, Garcia-Sanchez C, Llebaria G, Pascual-Sedano B, Gironell A, Kulisevsky J. Controlled study of decision-making and cognitive impairment in Parkinson's disease. Mov Disord 2007;22:1430-1435.
16. Tranel D. Non-conscious brain processing indexed by psychophysiological measures. Prog Brain Res 2000;122:317-332.
17. Bechara A, Damasio H, Damasio AR, Lee GP. Different contributions of the human amygdala and ventromedial prefrontal cortex to decision-making. J Neurosci 1999;19:5473-5481.
18. Finn PR, Justus AN, Mazas C, Rorick L, Steinmetz JE. Constraint, alcoholism, and electrodermal response in aversive classical conditioning and mismatch novelty paradigms. Integr Physiol Behav Sci 2001;36:154-167.
19. Levin BE, Llabre MM, Weiner WJ. Cognitive impairments associated with early Parkinson's disease. Neurology 1989;39:557-561.
20. Taylor AE, Saint-Cyr JA, Lang AE, Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. Brain 1986;109:845-883.
21. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 1986;9:357-381.
22. Ouchi Y, Kanno T, Okada H, et al. Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson's disease: a double-tracer positron emission tomography study. Ann Neurol 1999;46:723-731.
23. Braak H, Bohl JR, Muller CM, Rub U, de Vos RA, Del Tredici K. Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov Disord 2006;21:2042-2051.
24. Ouchi Y, Kanno T, Okada H, et al. Changes in dopamine, availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease. Brain 2001;124:784-792.
25. Ouchi Y, Yoshikawa E, Okada H, et al. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for β-CFT binding with positron emission tomography. Ann Neurol 1999;45:601-610.
26. Saito Y, Kawashima A, Ruberu NN, et al. Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol 2003;62:644-654.
27. Kawamura M, Koyama S. Impaired perception of facial expression, color, and smell as early symptoms of Parkinson's disease. CNS Drugs (in press).
28. Stone VE, Baron-Cohen S, Calder A, Keane J, Young A. Acquired theory of mind impairments in individuals with bilateral amygdala lesions. Neuropsychologia 2003;41:209-220.
29. Masaoka Y, Yoshimura N, Inoue M, Kawamura M, Homma I. Impairment of odor recognition in Parkinson's disease caused by weak activations of the orbitofrontal cortex. Neurosci Lett 2007; 412:45-50.
30. LeDoux J. Fear and the brain: where have we been, and where are we going? Biol Psychiatry 1998;44:1229-1238.
31. Emery NJ, Capitanio JP, Mason WA, Machado CJ, Mendoza SP, Amaral DG. The effects of bilateral lesions of the amygdala on dyadic social interactions in rhesus monkeys (Macaca mulatta). Behav Neurosci 2001;115:515-544.
32. Meunier M, Bachevalier J, Murray EA, Malkova L, Mishkin M. Effects of aspiration versus neurotoxic lesions of the amygdala on emotional responses in monkeys. Eur J Neurosci 1999;11:4403-4418.
33. Blair RJ, Cipolotti L. Impaired social response reversal. A case of acquired sociopathy. Brain 2000;123:1122-1141.
34. O'Doherty J. Can't learn without you: predictive value coding in orbitofrontal cortex requires the basolateral amygdala. Neuron 2003;39:731-733.
35. Bechara A, Damasio H, Damasio AR. Role of the amygdala in decision-making. Ann NY Acad Sci 2003;985:356-369.